PLOS
open access
CC BY 4.0
Integrative transcriptomics and reverse network pharmacology prioritize DPP4 and <i>Achyranthes bidentata</i> in Barrett’s esophagus
Barrett's esophagus (BE) is a precursor of esophageal adenocarcinoma, but candidate expression markers and preventive hypotheses require evaluation across patients, cohorts, and evidence levels. We analyzed two GPL96 discovery cohorts comprising 15 matched normal–BE pairs, used pair-aware different
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Early events during neoplastic progression in Barrett's esophagus#129209
- Barrett Esophagus: Risk Factors for Progression to Dysplasia and Adenocarcinoma.#636036
- A prospective cohort study evaluating disease-specific mortality in patients with early-stage Barrett's esophagus-related neoplasia following endoscopic therapy.#282970
- Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus#1096779
- Barrett's Esophagus & Gastroesophageal Reflux Disease#1010599
Record · ID 1092069
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive